FSMDX
Price
$33.25
Change
+$0.44 (+1.34%)
Updated
May 8 closing price
Net Assets
37.69B
MXNZX
Price
$7.80
Change
+$0.09 (+1.17%)
Updated
May 8 closing price
Net Assets
1.38B
Ad is loading...

FSMDX vs MXNZX

Header iconFSMDX vs MXNZX Comparison
Open Charts FSMDX vs MXNZXBanner chart's image
Fidelity Mid Cap Index
Price$33.25
Change+$0.44 (+1.34%)
VolumeN/A
Net Assets37.69B
Empower S&P Mid Cap 400® Index Instl
Price$7.80
Change+$0.09 (+1.17%)
VolumeN/A
Net Assets1.38B
FSMDX vs MXNZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMDX vs. MXNZX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and MXNZX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 37.7B vs. MXNZX (1.38B). MXNZX pays higher dividends than FSMDX: MXNZX (3.82) vs FSMDX (1.21). FSMDX was incepted earlier than MXNZX: FSMDX (14 years) vs MXNZX (10 years). MXNZX (0.18) is less costly to investors than FSMDX (0.03). MXNZX is a more actively managed with annual turnover of: 17.00 vs. FSMDX (8.00). FSMDX (0) and MXNZX (0) have matching initial minimum investment requirements. FSMDX annual gain was more profitable for investors over the last year : 5.24 vs. MXNZX (-5.20). FSMDX return over 5 years is better than : 75.46 vs. MXNZX (23.23).
FSMDXMXNZXFSMDX / MXNZX
Total Expense Ratio0.030.1814%
Annual Report Gross Expense Ratio0.030.1814%
Fund Existence14 years10 years-
Gain YTD-2.843-6.20446%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets37.7B1.38B2,728%
Annual Yield % from dividends1.213.8232%
Returns for 1 year5.24-5.20-101%
Returns for 3 years29.170.348,489%
Returns for 5 years75.4623.23325%
Returns for 10 years98.68-2.19-4,516%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POAI1.070.06
+5.94%
Predictive Oncology
H126.953.10
+2.50%
Hyatt Hotels Corp
CHGG0.720.01
+1.40%
CHEGG
ISPR2.90N/A
N/A
Ispire Technology
OR23.71-0.27
-1.13%
Osisko Gold Royalties Ltd